[
    [
        {
            "time": "2023-10-01",
            "original_text": "东北制药“混改”中途：国资股东清仓，对标恒瑞医药“压力山大”",
            "features": {
                "keywords": [
                    "东北制药",
                    "混改",
                    "国资股东",
                    "清仓",
                    "恒瑞医药",
                    "压力"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "东北制药“混改”中途：国资股东清仓，对标恒瑞医药“压力山大”",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-02",
            "original_text": "外资流入A股系列27：电子、计算机位列6月陆股通净流入前二",
            "features": {
                "keywords": [
                    "外资",
                    "A股",
                    "电子",
                    "计算机",
                    "陆股通",
                    "净流入"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电子",
                    "计算机"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "外资流入A股系列27：电子、计算机位列6月陆股通净流入前二",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-03",
            "original_text": "医药行业：创新药和CXO行业加速结构化进程",
            "features": {
                "keywords": [
                    "医药行业",
                    "创新药",
                    "CXO",
                    "结构化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业：创新药和CXO行业加速结构化进程",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-04",
            "original_text": "恒瑞医药价值迷局：集采失利再遭肿瘤药新规冲击，半年跌近40%市值蒸发2000亿 连续下跌",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "集采",
                    "肿瘤药",
                    "新规",
                    "下跌",
                    "市值蒸发"
                ],
                "sentiment_score": -0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药价值迷局：集采失利再遭肿瘤药新规冲击，半年跌近40%市值蒸发2000亿 连续下跌",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "北向资金净流出0.6亿元，抢筹恒瑞医药2.46亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流出",
                    "恒瑞医药",
                    "抢筹"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金净流出0.6亿元，抢筹恒瑞医药2.46亿元",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-06",
            "original_text": "白马失蹄！8款创新药上市仍暴跌，恒瑞怎么了？",
            "features": {
                "keywords": [
                    "白马",
                    "创新药",
                    "上市",
                    "暴跌",
                    "恒瑞"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白马失蹄！8款创新药上市仍暴跌，恒瑞怎么了？",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-07",
            "original_text": "速读社丨GSK在沪设立全国商业营运中心 AZ斥390亿美元收购Alexion取得进展",
            "features": {
                "keywords": [
                    "GSK",
                    "商业营运中心",
                    "AZ",
                    "收购",
                    "Alexion"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "速读社丨GSK在沪设立全国商业营运中心 AZ斥390亿美元收购Alexion取得进展",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-08",
            "original_text": "北向资金今日小幅净卖出0.6亿元，士兰微、中国中免、比亚迪等净卖出超3亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净卖出",
                    "士兰微",
                    "中国中免",
                    "比亚迪"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电子",
                    "消费",
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金今日小幅净卖出0.6亿元，士兰微、中国中免、比亚迪等净卖出超3亿元",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-09",
            "original_text": "恒瑞医药：甲磺酸阿帕替尼片获得药物临床试验批准通知书",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "甲磺酸阿帕替尼片",
                    "临床试验",
                    "批准"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药：甲磺酸阿帕替尼片获得药物临床试验批准通知书",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "大白马被宰了！股价半年跌近35%，恒瑞医药市值跌破4000亿关口 连续下跌",
            "features": {
                "keywords": [
                    "大白马",
                    "股价",
                    "下跌",
                    "恒瑞医药",
                    "市值"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "大白马被宰了！股价半年跌近35%，恒瑞医药市值跌破4000亿关口 连续下跌",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]